TD Cowen Forecasts Strong Price Appreciation for Globe Life (NYSE:GL) Stock

Globe Life (NYSE:GL) had its target price upped by equities research analysts at TD Cowen from $215.00 to $225.00 in a note issued to investors on Wednesday,Benzinga reports. The firm presently has a “buy” rating on the stock. TD Cowen’s price objective would suggest a potential upside of 31.85% from the stock’s current price.

A number of other research firms have also recently weighed in on GL. Keefe, Bruyette & Woods lifted their price target on Globe Life from $180.00 to $192.00 and gave the company an “outperform” rating in a report on Monday, July 13th. Piper Sandler increased their price objective on Globe Life from $175.00 to $200.00 and gave the stock an “overweight” rating in a report on Wednesday, July 15th. Weiss Ratings cut Globe Life from a “buy (b)” rating to a “buy (b-)” rating in a research report on Monday. Morgan Stanley lifted their target price on Globe Life from $181.00 to $208.00 and gave the company an “overweight” rating in a research note on Monday, July 6th. Finally, Jefferies Financial Group boosted their price target on Globe Life from $147.00 to $166.00 and gave the stock a “hold” rating in a research report on Friday, July 10th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $187.60.

Globe Life Stock Performance

GL stock opened at $170.65 on Wednesday. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.07 and a current ratio of 0.07. The stock has a market capitalization of $13.25 billion, a price-to-earnings ratio of 11.33 and a beta of 0.47. Globe Life has a 1 year low of $123.00 and a 1 year high of $191.55. The stock’s fifty day moving average is $168.70 and its two-hundred day moving average is $152.76.

Globe Life (NYSE:GL) last released its quarterly earnings data on Wednesday, July 22nd. The company reported $3.61 earnings per share for the quarter, missing analysts’ consensus estimates of $3.67 by ($0.06). The firm had revenue of $1.60 billion during the quarter, compared to analyst estimates of $1.59 billion. Globe Life had a return on equity of 20.73% and a net margin of 19.58%.The firm’s revenue was up 8.0% on a year-over-year basis. During the same period last year, the business earned $3.05 EPS. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. On average, research analysts predict that Globe Life will post 15.64 EPS for the current year.

Insider Activity at Globe Life

In other news, Director Cheryl Alston sold 8,258 shares of the stock in a transaction that occurred on Thursday, June 25th. The shares were sold at an average price of $179.24, for a total value of $1,480,163.92. Following the completion of the transaction, the director directly owned 16,621 shares in the company, valued at $2,979,148.04. This trade represents a 33.19% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CFO Thomas Peter Kalmbach sold 15,637 shares of the firm’s stock in a transaction that occurred on Monday, May 11th. The shares were sold at an average price of $153.65, for a total transaction of $2,402,625.05. Following the transaction, the chief financial officer owned 45,335 shares in the company, valued at $6,965,722.75. This represents a 25.65% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 90,187 shares of company stock valued at $14,299,874. Insiders own 2.11% of the company’s stock.

Institutional Trading of Globe Life

Hedge funds and other institutional investors have recently modified their holdings of the company. CYBER HORNET ETFs LLC acquired a new stake in shares of Globe Life in the second quarter valued at $28,000. Hilton Head Capital Partners LLC acquired a new position in Globe Life during the fourth quarter worth about $30,000. MUFG Securities EMEA plc bought a new stake in Globe Life in the second quarter worth about $31,000. Torren Management LLC bought a new stake in Globe Life in the fourth quarter worth about $37,000. Finally, AdvisorNet Financial Inc lifted its holdings in Globe Life by 41.1% in the 1st quarter. AdvisorNet Financial Inc now owns 316 shares of the company’s stock valued at $44,000 after acquiring an additional 92 shares during the last quarter. Institutional investors own 81.61% of the company’s stock.

Key Globe Life News

Here are the key news stories impacting Globe Life this week:

• Positive Sentiment: Globe Life raised its FY 2026 EPS guidance to $15.55-$15.95, signaling management confidence in the business outlook. Globe Life Inc. Reports Second Quarter 2026 Results
• Positive Sentiment: Quarterly revenue rose 8% year over year to $1.60 billion, slightly ahead of estimates, helped by broad underwriting gains and stronger investment income. Insurer Globe Life’s second-quarter profit rises on strong underwriting income
• Positive Sentiment: TD Cowen raised its price target on Globe Life to $225 and kept a buy rating, reflecting a constructive view on the stock’s longer-term potential. Benzinga
• Neutral Sentiment: Net operating income was $3.61 per share, improving from $3.27 a year ago but just below the consensus estimate of $3.67. Globe Life Inc. Reports Second Quarter 2026 Results
• Negative Sentiment: Operating expenses escalated enough to pressure the quarter and contribute to the earnings miss, which may be the main reason investors are selling the stock today. Globe Life Q2 Earnings Miss Estimates on Escalating Expenses

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.